GIF inhibits Th effector generation by acting on antigen-presenting B cells

J Immunol. 2001 Apr 1;166(7):4473-80. doi: 10.4049/jimmunol.166.7.4473.

Abstract

Glycosylation-inhibiting factor (GIF) is a 13-kDa cytokine secreted from T cells. Administration of bioactive recombinant GIF inhibits IgG1 and IgE Ab responses in vivo. Treatment of B cells with the cytokine reduces the secretion of IgG1 and IgE induced by LPS and IL-4. To examine the effect on cognate T-B interaction, GIF was added to low-density B cells from MD4 transgenic (Tg) mice, which express B cell receptor specific for hen egg lysozyme (HEL). The B cells were subsequently pulsed with HEL-OVA conjugate and cultured with OVA-specific naive CD4 T cells from DO11.10 Tg mice. Treatment of Ag-presenting B cells with GIF reduced expansion and IL-2 secretion of naive T cells and rendered them hyporesponsive to antigenic restimulation, resulting in 50--95% reduction of IL-4 and IFN-gamma secretion upon restimulation with Ag. GIF dramatically inhibited Th effector generation when it was added to B cells before pulsing with HEL-OVA, whereas it showed little to no effect when added after B cells were pulsed with Ag. GIF was more effective when B cells from MD4 Tg mice were pulsed with HEL-OVA than when they were pulsed with OVA. This cytokine did not affect Th effector generation when B cells or irradiated splenocytes pulsed with OVA(323--339) peptide stimulated naive DO11.10 T cells. Confocal microscopy revealed that GIF inhibited internalization of HEL by B cells from MD4 Tg mice. Therefore, the cytokine may regulate early steps of Ag presentation involving B cell receptors to diminish Th effector generation from naive CD4 T cells.

MeSH terms

  • Animals
  • Antigen Presentation
  • Antigen-Presenting Cells / immunology*
  • Antigen-Presenting Cells / metabolism
  • B-Lymphocytes / immunology*
  • B-Lymphocytes / metabolism
  • CD4-Positive T-Lymphocytes / cytology
  • CD4-Positive T-Lymphocytes / immunology
  • Cell Differentiation / immunology
  • Cells, Cultured
  • Cysteine / genetics
  • Cysteine / metabolism
  • Glycosylation
  • Growth Inhibitors / pharmacology
  • Humans
  • Immunosuppressive Agents / pharmacology*
  • Interphase / immunology
  • Lymphocyte Activation / immunology*
  • Lymphokines / genetics
  • Lymphokines / pharmacology*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Muramidase / immunology
  • Muramidase / metabolism
  • Ovalbumin / immunology
  • Ovalbumin / metabolism
  • Peptides / immunology
  • Peptides / metabolism
  • Prostatic Secretory Proteins*
  • Receptors, Antigen, B-Cell / physiology
  • Recombinant Proteins / pharmacology
  • T-Lymphocytes, Helper-Inducer / cytology
  • T-Lymphocytes, Helper-Inducer / immunology*
  • T-Lymphocytes, Helper-Inducer / metabolism
  • Th2 Cells / immunology
  • Th2 Cells / metabolism

Substances

  • Growth Inhibitors
  • Immunosuppressive Agents
  • Lymphokines
  • Peptides
  • Prostatic Secretory Proteins
  • Receptors, Antigen, B-Cell
  • Recombinant Proteins
  • beta-microseminoprotein
  • immunoglobulin-binding factors
  • Ovalbumin
  • Muramidase
  • Cysteine